Latest New Drug Application Stories
Biohaven filed a pre-IND meeting request with the FDA regarding lead investigational agent BHV-0223, receives written response in lieu of an in-person meeting TORONTO, Dec.
Expects to complete submission in the first half of 2015 DUBLIN, Dec.
IGI Now Has Nineteen Applications Pending at the FDA BUENA, N.J., Dec. 1, 2014 /PRNewswire/ -- IGI Laboratories, Inc.
CORK, Ireland, November 27, 2014 /PRNewswire/ -- Hovione announced today it has filed its first Investigational New Drug (IND) Application with the U.S.
--Company Plans to Complete a New Human Factor Validation Study and Respond to the CRL in the First Half of Calendar 2015-- ALISO VIEJO, Calif., Nov.
BUENA, N.J., Nov. 24, 2014 /PRNewswire/ -- IGI Laboratories, Inc.
FDA Can Use Existing Authority to Lower Drug Costs for Consumers, Employers and Public Programs Washington D.C.
FDA Can Use Existing Authority to Lower Drug Costs for Consumers, Employers and Public Programs WASHINGTON, Nov.
ALISO VIEJO, Calif., Nov. 7, 2014 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced that the U.S.
-- Optimizes resources by leveraging shared-services -- HAYWARD, Calif., Oct.
- a meat pie that is usually eaten at Christmas in Quebec